2,239
Views
57
CrossRef citations to date
0
Altmetric
Original

Dissecting the role of hyperthermia in natural killer cell mediated anti-tumor responses

, , &
Pages 41-56 | Received 17 Oct 2007, Accepted 11 Dec 2007, Published online: 09 Jul 2009

References

  • Nauts HC, McLaren JR. Coley toxins - The first century. Adv Exp Med Biol 1990; 267: 483–500
  • Wust P, et al. Hyperthermia in combined treatment of cancer. Lancet Oncol 2002; 3: 487–497
  • Harima Y, et al. A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma. Int J Hyperthermia 2001; 17: 97–105
  • Dewhirst MW, et al. Re-setting the biologic rationale for thermal therapy. Int J Hyperthermia 2005; 21: 779–790
  • Sharma S, et al. Side-effects of local hyperthermia: Results of a prospectively randomized clinical study. Int J Hyperthermia 1990; 6: 279–285
  • Sneed PK, et al. Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/− hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1998; 40: 287–295
  • van der Zee J, et al. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 2000; 355: 1119–1125
  • Falk MH, Issels RD. Hyperthermia in oncology. Int J Hyperthermia 2001; 17: 1–18
  • Issels R, Schlemmer M, Lindner L. The role of hyperthermia in combined treatment in the management of soft tissue sarcoma. Curr Oncol Rep 2006; 8: 305–309
  • Corry PM, Armour EP. The heat shock response: Role in radiation biology and cancer therapy. Int J Hyperthermia 2005; 21: 769–778
  • Horsman MR, Overgaard J. Can mild hyperthermia improve tumour oxygenation?. Int J Hyperthermia 1997; 13: 141–147
  • Shakil A, Osborn JL, Song CW. Changes in oxygenation status and blood flow in a rat tumor model by mild temperature hyperthermia. Int J Radiat Oncol Biol Phys 1999; 43: 859–865
  • Song CW, et al. Implications of increased tumor blood flow and oxygenation caused by mild temperature hyperthermia in tumor treatment. Int J Hyperthermia 2005; 21: 761–767
  • Thrall DE, et al. Changes in tumour oxygenation during fractionated hyperthermia and radiation therapy in spontaneous canine sarcomas. Int J Hyperthermia 2006; 22: 365–373
  • Repasky EA, Issels RD. Hyperthermia and the Immune System. Int J Hyperthermia 2002; 18: 485–615
  • Ostberg JR, Repasky EA. Emerging evidence indicates that physiologically relevant thermal stress regulates dendritic cell function. Cancer Immunol Immunother 2006; 55: 292–298
  • Wang XY, Ostberg JR, Repasky EA. Effect of fever-like whole-body hyperthermia on lymphocyte spectrin distribution protein kinase C activity and uropod formation. J Immunol 1999; 162: 3378–3387
  • Di YP, Repasky EA, Subjeck JR. Distribution of HSP70 protein kinase C and spectrin is altered in lymphocytes during a fever-like hyperthermia exposure. Journal of Cellular Physiology 1997; 172: 44–54
  • Noessner E. Thermal stress-related modulation of tumor cell physiology and immune responses. Cancer Immunol Immunother 2006; 55: 289–291
  • Chen Q, et al. Dynamic control of lymphocyte trafficking by fever-range thermal stress. Cancer Immunol Immunother 2006; 55: 299–311
  • Multhoff G, et al. CD3- large granular lymphocytes recognize a heat-inducible immunogenic determinant associated with the 72-kD heat shock protein on human sarcoma cells. Blood 1995; 86: 1374–1382
  • Ljunggren HG, Karre K. In search of the ‘missing self’: MHC molecules and NK cell recognition. Immunol Today 1990; 11: 237–244
  • Karre K. NK cells MHC class I molecules and the missing self. Scand J Immunol 2002; 55: 221–228
  • O'Leary JG, et al. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol 2006; 7: 507–516
  • Kelly JM, et al. Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection. Nat Immunol 2002; 3: 83–90
  • Biron CA, et al. Natural killer cells in antiviral defense: Function and regulation by innate cytokines. Annu Rev Immunol 1999; 17: 189–220
  • Smyth MJ, et al. An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum. J Exp Med 1998; 188: 1611–1619
  • Pilaro AM, et al. TNF-alpha is a principal cytokine involved in the recruitment of NK cells to liver parenchyma. J Immunol 1994; 153: 333–342
  • Young HA, Ortaldo J. Cytokines as critical co-stimulatory molecules in modulating the immune response of natural killer cells. Cell Res 2006; 16: 20–24
  • Lotzova E. Definition and functions of natural killer cells. Nat Immun 1993; 12: 169–176
  • Nguyen KB, et al. Coordinated and distinct roles for IFN-alpha beta IL-12 and IL-15 regulation of NK cell responses to viral infection. J Immunol 2002; 169: 4279–4287
  • Carson WE, et al. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 1994; 180: 1395–1403
  • Kluger MJ. Fever revisited. Pediatrics 1992; 90: 846–850
  • Scholz H. Fever. Am J Physiol Regul Integr Comp Physiol 2003; 284: R913–R915
  • Ho EL, et al. Costimulation of multiple NK cell activation receptors by NKG2D. J Immunol 2002; 169: 3667–3675
  • Jamieson AM, et al. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 2002; 17: 19–29
  • Regunathan J, et al. NKG2D receptor-mediated NK cell function is regulated by inhibitory Ly49 receptors. Blood 2005; 105: 233–240
  • Sivori S, et al. NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous allogeneic or xenogeneic target cells. Eur J Immunol 1999; 29: 1656–1666
  • Pende D, et al. Identification and molecular characterization of NKp30 a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J Exp Med 1999; 190: 1505–1516
  • Vitale M, et al. NKp44 a novel triggering surface molecule specifically expressed by activated natural killer cells is involved in non-major histocompatibility complex-restricted tumor cell lysis. J Exp Med 1998; 187: 2065–2072
  • Bottino C, et al. The human natural cytotoxicity receptors (NCR) that induce HLA class I-independent NK cell triggering. Hum Immunol 2000; 61: 1–6
  • Borrego F, et al. Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells. Mol Immunol 2002; 38: 637–660
  • McQueen KL, Parham P. Variable receptors controlling activation and inhibition of NK cells. Curr Opin Immunol 2002; 14: 615–621
  • Smyth MJ, Godfrey DI, Trapani JA. A fresh look at tumor immunosurveillance and immunotherapy. Nat Immunol 2001; 2: 293–299
  • Lou Z, et al. A balance between positive and negative signals in cytotoxic lymphocytes regulates the polarization of lipid rafts during the development of cell-mediated killing. J Exp Med 2000; 191: 347–354
  • Zanker KS, Lange J. Whole body hyperthermia and natural killer cell activity. Lancet 1982; 1: 1079–1080
  • Nakayama J, et al. Kinetics of immunological parameters in patients with malignant melanoma treated with hyperthermic isolated limb perfusion. J Dermatol Sci 1997; 15: 1–8
  • Szmigielski S, et al. Effects of local prostatic hyperthermia on human NK and T cell function. Int J Hyperthermia 1991; 7: 869–880
  • Robins HI, et al. Phase I trial of human lymphoblastoid interferon with whole body hyperthermia in advanced cancer. Cancer Res 1989; 49: 1609–1615
  • Blazickova S, et al. Effect of hyperthermic water bath on parameters of cellular immunity. Int J Clin Pharmacol Res 2000; 20: 41–46
  • Kraybill WG, et al. A phase I study of fever-range whole body hyperthermia (FR-WBH) in patients with advanced solid tumours: Correlation with mouse models. Int J Hyperthermia 2002; 18: 253–266
  • Ahlers O, et al. Stress induced changes in lymphocyte subpopulations and associated cytokines during whole body hyperthermia of 41.8–42.2°C. Eur J Appl Physiol 2005; 95: 298–306
  • Atanackovic D, et al. Patients with solid tumors treated with high-temperature whole body hyperthermia show a redistribution of naive/memory T-cell subtypes. Am J Physiol Regul Integr Comp Physiol 2006; 290: R585–R594
  • Tomiyama-Miyaji C, et al. Modulation of the endocrine and immune systems by well-controlled hyperthermia equipment. Biomed Res 2007; 28: 119–125
  • Fujieda S, et al. Heat shock enhances the susceptibility of tumor cells to lysis by lymphokine-activated killer cells. Arch Otolaryngol Head Neck Surg 1995; 121: 1009–1014
  • Kim JY, et al. Increase of NKG2D ligands and sensitivity to NK cell-mediated cytotoxicity of tumor cells by heat shock and ionizing radiation. Exp Mol Med 2006; 38: 474–484
  • Ostberg JR, et al. Enhancement of natural killer (NK) cell cytotoxicity by fever-range thermal stress is dependent on NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells. J Leukoc Biol 2007
  • Burd R, et al. Tumor cell apoptosis lymphocyte recruitment and tumor vascular changes are induced by low temperature long duration (fever-like) whole body hyperthermia. J Cell Physiol 1998; 177: 137–147
  • Kubes J, et al. Immunological response in the mouse melanoma model after local hyperthermia. Physiol Res 2007
  • Azocar J, Yunis EJ, Essex M. Sensitivity of human natural killer cells to hyperthermia. Lancet 1982; 1: 16–17
  • Nurmi T, Uhari M, Kouvalainen K. Temperature and natural killer cell activity. Lancet 1982; 1: 516–517
  • Dinarello CA, et al. Inhibitory effects of elevated temperature on human cytokine production and natural killer activity. Cancer Res 1986; 46: 6236–6241
  • Won SJ, Lin MT. Thermal stresses reduce natural killer cell cytotoxicity. J Appl Physiol 1995; 79: 732–737
  • Ozveri ES, et al. The effect of hyperthermic preconditioning on the immune system in rat peritonitis. Intensive Care Med 1999; 25: 1155–1159
  • Gulluoglu BM, et al. Optimal timing and temperature for hyperthermic preconditioning in an animal model of fecal peritonitis. J Invest Surg 2002; 15: 117–124
  • Nakayama J, et al. Experimental approaches for the treatment of murine B16 melanomas of various sizes. I: Local injection of ethanol with a combination of interleukin-2 or microwaval hyperthermia for B16 melanomas with a size of less than 7 mm in diameter. J Dermatol Sci 1997; 15: 75–81
  • Nakayama J, et al. A combined therapeutic modality with hyperthermia and locally administered rIFN-beta inhibited the growth of B16 melanoma in association with the modulation of cellular infiltrates. J Dermatol Sci 1993; 6: 240–246
  • Nakayama J, et al. Experimental approaches for the treatment of murine B16 melanomas of various sizes. II: Injection of ethanol with combinations of beta-interferon and microwaval hyperthermia for B16 melanomas with a size of greater than 10 mm in diameter. J Dermatol Sci 1997; 15: 82–88
  • Nakayama J, et al. In situ detection of immunocompetent cells in murine B16 melanoma locally treated with interleukin-2 or microwaval hyperthermia. Pigment Cell Res 1993; 6: 111–116
  • Jaattela M. Effects of heat shock on cytolysis mediated by NK cells LAK cells activated monocytes and TNFs alpha and beta. Scand J Immunol 1990; 31: 175–182
  • Milani V, Noessner E. Effects of thermal stress on tumor antigenicity and recognition by immune effector cells. Cancer Immunol Immunother 2006; 55: 312–319
  • Fleischmann WR, Jr, Fleischmann CM, Gindhart TD. Effect of hyperthermia on the antiproliferative activities of murine alpha- beta- and gamma-interferon: Differential enhancement of murine gamma-interferon. Cancer Res 1986; 46: 8–13
  • Eleme K, et al. Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2D. J Exp Med 2004; 199: 1005–1010
  • Endt J, et al. Inhibitory receptor signals suppress ligation-induced recruitment of NKG2D to GM1-rich membrane domains at the human NK cell immune synapse. J Immunol 2007; 178: 5606–5611
  • Tanaka M, et al. Effect of heat-pretreatment on interleukin-2-activated killer cells for in vitro purging. Pathobiology 2000; 68: 124–128
  • Lamon EW, et al. Synergistic induction of thermotolerance in murine natural killer cells by interferon alpha and mild heat shock. Radiat Res 1994; 139: 364–369
  • Raulet DH, Vance RE. Self-tolerance of natural killer cells. Nat Rev Immunol 2006; 6: 520–531
  • Blom DJ, et al. Effect of hyperthermia on expression of histocompatibility antigens and heat-shock protein molecules on three human ocular melanoma cell lines. Melanoma Res 1997; 7: 103–109
  • Multhoff G. Heat shock protein 72 (HSP72) a hyperthermia-inducible immunogenic determinant on leukemic K562 and Ewing's sarcoma cells. Int J Hyperthermia 1997; 13: 39–48
  • Ito A, et al. Augmentation of MHC class I antigen presentation via heat shock protein expression by hyperthermia. Cancer Immunol Immunother 2001; 50: 515–522
  • Kubista B, et al. Hyperthermia increases the susceptibility of chondro- and osteosarcoma cells to natural killer cell-mediated lysis. Anticancer Res 2002; 22: 789–792
  • Roigas J, et al. Heat shock protein (HSP72) surface expression enhances the lysis of a human renal cell carcinoma by IL-2 stimulated NK cells. Adv Exp Med Biol 1998; 451: 225–229
  • Basu S, Srivastava PK. Fever-like temperature induces maturation of dendritic cells through induction of HSP90. Int Immunol 2003; 15: 1053–1061
  • Gastpar R, et al. Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. Cancer Res 2005; 65: 5238–5247
  • Gastpar R, et al. The cell surface-localized heat shock protein 70 epitope TKD induces migration and cytolytic activity selectively in human NK cells. J Immunol 2004; 172: 972–980
  • Zhang H, et al. Comparison of the anti-tumor effects of various whole-body hyperthermia protocols: Correlation with HSP 70 expression and composition of splenic lymphocytes. Immunol Invest 2005; 34: 245–258
  • Jantschitsch C, et al. Overexpression of Hsp25 in K1735 murine melanoma cells enhances susceptibility to natural killer cytotoxicity. Cell Stress Chaperones 2002; 7: 107–117
  • Gross C, et al. Cell surface-bound heat shock protein 70 (Hsp70) mediates perforin-independent apoptosis by specific binding and uptake of granzyme B. J Biol Chem 2003; 278: 41173–41181
  • Gross C, et al. Heat shock protein 70-reactivity is associated with increased cell surface density of CD94/CD56 on primary natural killer cells. Cell Stress Chaperones 2003; 8: 348–360
  • Tanaka K, et al. Intratumoral injection of immature dendritic cells enhances antitumor effect of hyperthermia using magnetic nanoparticles. Int J Cancer 2005; 116: 624–633
  • Milani V, et al. Heat shock protein 70: Role in antigen presentation and immune stimulation. Int J Hyperthermia 2002; 18: 563–575
  • Multhoff G. Activation of natural killer cells by heat shock protein 70. Int J Hyperthermia 2002; 18: 576–585
  • Yang Y, Li Z. Roles of heat shock protein gp96 in the ER quality control: redundant or unique function?. Mol Cells 2005; 20: 173–182
  • Kozutsumi Y, et al. The presence of malfolded proteins in the endoplasmic reticulum signals the induction of glucose-regulated proteins. Nature 1988; 332: 462–464
  • Pilla L, et al. Natural killer and NK-Like T-cell activation in colorectal carcinoma patients treated with autologous tumor-derived heat shock protein 96. Cancer Res 2005; 65: 3942–3949
  • Shinagawa N, et al. Immunotherapy with dendritic cells pulsed with tumor-derived gp96 against murine lung cancer is effective through immune response of CD8(+) cytotoxic T lymphocytes and natural killer cells. Cancer Immunol Immunother 2007
  • Bauer S, et al. Activation of NK cells and T cells by NKG2D a receptor for stress-inducible MICA. Science 1999; 285: 727–729
  • Diefenbach A, Raulet DH. Natural killer cells: Stress out turn on tune in. Curr Biol 1999; 9: R851–R853
  • Groh V, et al. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci USA 1996; 93: 12445–12450
  • Venkataraman GM, et al. Promoter region architecture and transcriptional regulation of the genes for the MHC class I-related chain A and B ligands of NKG2D. J Immunol 2007; 178: 961–969
  • Rodriguez-Rodero S, et al. Transcriptional regulation of MICA and MICB: A novel polymorphism in MICB promoter alters transcriptional regulation by Sp1. Eur J Immunol 2007; 37: 1938–1953
  • Davis DM, et al. The human natural killer cell immune synapse. Proc Natl Acad Sci USA 1999; 96: 15062–15067
  • Vyas YM, et al. Spatial organization of signal transduction molecules in the NK cell immune synapses during MHC class I-regulated noncytolytic and cytolytic interactions. J Immunol 2001; 167: 4358–4567
  • McCann FE, et al. The activating NKG2D ligand MHC class I-related chain A transfers from target cells to NK cells in a manner that allows functional consequences. J Immunol 2007; 178: 3418–3426
  • Roda-Navarro P, et al. Transfer of NKG2D and MICB at the cytotoxic NK cell immune synapse correlates with a reduction in NK cell cytotoxic function. Proc Natl Acad Sci USA 2006; 103: 11258–11263
  • McCann FE, et al. The size of the synaptic cleft and distinct distributions of filamentous actin ezrin CD43 and CD45 at activating and inhibitory human NK cell immune synapses. J Immunol 2003; 170: 2862–2870
  • Salih HR, Rammensee HG, Steinle A. Cutting edge: Down-regulation of MICA on human tumors by proteolytic shedding. J Immunol 2002; 169: 4098–4102
  • Salih HR, Goehlsdorf D, Steinle A. Release of MICB molecules by tumor cells: Mechanism and soluble MICB in sera of cancer patients. Hum Immunol 2006; 67: 188–195
  • Waldhauer I, Steinle A. Proteolytic release of soluble UL16-binding protein 2 from tumor cells. Cancer Res 2006; 66: 2520–2526
  • Onsrud M. Effects of hyperthermia on human natural killer cells. Acta Pathol Microbiol Immunol Scand [C] 1983; 91: 1–8
  • Kalland T, Dahlquist I. Effects of in vitro hyperthermia on human natural killer cells. Cancer Res 1983; 43: 1842–1846
  • Johnston RL, et al. Effects of in vivo ultrasound hyperthermia on natural killer cell cytotoxicity in the hamster. Bioelectromagnetics 1986; 7: 283–293
  • Downing JF, Taylor MW. The effect of in vivo hyperthermia on selected lymphokines in man. Lymphokine Res 1987; 6: 103–109
  • Hughes CS, et al. Effects of hyperthermia on spectrin expression patterns of murine lymphocytes. Radiat Res 1987; 112: 116–123
  • Shen RN, et al. Effect of whole-body hyperthermia and cyclophosphamide on natural killer cell activity in murine erythroleukemia. Cancer Res 1988; 48: 4561–4563
  • Yoshioka A, Miyachi Y, Imamura S. Immunological effects of in vitro hyperthermia. J Clin Lab Immunol 1989; 29: 95–97
  • Yang H, Mitchel R, Lemaire I. The effects of in vitro hyperthermia on natural killer activity from lung blood and spleen. J Clin Lab Immunol 1990; 32: 117–122
  • Yoshioka A, et al. Effects of local hyperthermia on natural killer activity in mice. Int J Hyperthermia 1990; 6: 261–267
  • Kappel M, et al. Effects of in vivo hyperthermia on natural killer cell activity in vitro proliferative responses and blood mononuclear cell subpopulations. Clin Exp Immunol 1991; 84: 175–180
  • Lu L, et al. Efficacy of recombinant human macrophage colony-stimulating factor in combination with whole-body hyperthermia in the treatment of mice infected with the polycythemia-inducing strain of the Friend virus complex. Exp Hematol 1991; 19: 804–809
  • Yang HX, Mitchel RE. Hyperthermic inactivation recovery and induced thermotolerance of human natural killer cell lytic function. Int J Hyperthermia 1991; 7: 35–49
  • Taradi M, et al. Augmentation of mouse natural killer cell activity by combined hyperthermia and streptococcal preparation OK-432 (Picibanil) treatment. Int J Hyperthermia 1991; 7: 653–665
  • Yang H, Lauzon W, Lemaire I. Effects of hyperthermia on natural killer cells: Inhibition of lytic function and microtubule organization. Int J Hyperthermia 1992; 8: 87–97
  • Lu L, et al. In vivo effects of purified recombinant human macrophage colony-stimulating factor in combination with local hyperthermia on tumor progression in B16a melanoma bearing mice. Int J Hematol 1993; 58: 139–152
  • Pedersen BK, Ullum H. NK cell response to physical activity: Possible mechanisms of action. Med Sci Sports Exerc 1994; 26: 140–146
  • Kappel M, et al. Somatostatin attenuates the hyperthermia induced increase in neutrophil concentration. Eur J Appl Physiol Occup Physiol 1998; 77: 149–156
  • Fuggetta MP, et al. In vitro effect of hyperthermia on natural cell-mediated cytotoxicity. Anticancer Res 2000; 20: 1667–1672
  • Payne J, et al. Mild hyperthermia modulates biological activities of interferons. Int J Hyperthermia 2000; 16: 492–507
  • Rabinovich BA, et al. Stress renders T cell blasts sensitive to killing by activated syngeneic NK cells. J Immunol 2000; 165: 2390–2397
  • Gulluoglu BM, et al. Immunologic influences of hyperthermia in a rat model of obstructive jaundice. Dig Dis Sci 2001; 46: 2378–2384
  • Atanackovic D, et al. 41.8 degrees C whole body hyperthermia as an adjunct to chemotherapy induces prolonged T cell activation in patients with various malignant diseases. Cancer Immunol Immunother 2002; 51: 603–613
  • Dieing A, et al. Whole body hyperthermia induces apoptosis in subpopulations of blood lymphocytes. Immunobiology 2003; 207: 265–273
  • Ostapenko VV, et al. Immune-related effects of local hyperthermia in patients with primary liver cancer. Hepatogastroenterology 2005; 52: 1502–1506
  • Koga T, et al. Hyperthermia suppresses the cytotoxicity of NK cells via down-regulation of perforin/granzyme B expression. Biochem Biophys Res Commun 2005; 337: 1319–1323
  • Capitano ML, et al. Fever-range whole body hyperthermia prevents the onset of type 1 diabetes in non-obese diabetic mice. Int J Hyperthermia 2008, (in press)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.